Eberhard Schulz

12.5k total citations · 3 hit papers
177 papers, 9.8k citations indexed

About

Eberhard Schulz is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Psychiatry and Mental health. According to data from OpenAlex, Eberhard Schulz has authored 177 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Physiology, 54 papers in Cardiology and Cardiovascular Medicine and 33 papers in Psychiatry and Mental health. Recurrent topics in Eberhard Schulz's work include Nitric Oxide and Endothelin Effects (51 papers), Eicosanoids and Hypertension Pharmacology (23 papers) and Cardiac Valve Diseases and Treatments (22 papers). Eberhard Schulz is often cited by papers focused on Nitric Oxide and Endothelin Effects (51 papers), Eicosanoids and Hypertension Pharmacology (23 papers) and Cardiac Valve Diseases and Treatments (22 papers). Eberhard Schulz collaborates with scholars based in Germany, United States and France. Eberhard Schulz's co-authors include Thomas Münzel, Andreas Daiber, Philip Wenzel, Matthias Oelze, John F. Keaney, Tommaso Gori, Swenja Kröller‐Schön, Thomas Jansen, Helmut Remschmidt and Maria Wendt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Eberhard Schulz

170 papers receiving 9.6k citations

Hit Papers

Increased NADH-Oxidase–Me... 1999 2026 2008 2017 1999 2002 2011 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis
    1999 574 citations Georg Nickenig, Eberhard Schulz et al. Circulation profile →
  2. Effects of Angiotensin II Infusion on the Expression and Function of NAD(P)H Oxidase and Components of Nitric Oxide/cGMP Signaling
    2002 561 citations Hanke Mollnau, Maria Wendt et al. profile →
  3. Lysozyme M–Positive Monocytes Mediate Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction
    2011 407 citations Philip Wenzel, Maike Knorr et al. Circulation profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Eberhard Schulz 3.6k 2.8k 2.5k 1.5k 1.3k 177 9.8k
Rita C. Tostes 2.4k 0.7× 2.2k 0.8× 2.7k 1.1× 2.5k 1.6× 1.3k 1.0× 311 9.2k
Ákos Koller 5.1k 1.4× 4.8k 1.7× 2.3k 0.9× 1.1k 0.7× 1.5k 1.2× 250 12.2k
Dan E. Berkowitz 4.2k 1.2× 2.6k 0.9× 2.8k 1.1× 621 0.4× 822 0.6× 188 9.2k
Christopher G. Sobey 3.7k 1.0× 2.1k 0.7× 4.7k 1.9× 1.3k 0.9× 1.1k 0.9× 232 15.3k
John Pernow 3.9k 1.1× 3.5k 1.3× 3.0k 1.2× 936 0.6× 1.8k 1.4× 272 10.3k
Jürgen C. Frölich 5.1k 1.4× 4.0k 1.4× 1.9k 0.8× 1.4k 0.9× 1.3k 1.0× 211 12.8k
Ismail Laher 3.8k 1.1× 1.9k 0.7× 2.4k 1.0× 1.0k 0.7× 806 0.6× 290 10.0k
Philip J. Kadowitz 3.9k 1.1× 2.5k 0.9× 3.5k 1.4× 2.3k 1.6× 1.7k 1.3× 475 12.4k
R. Clinton Webb 2.6k 0.7× 1.9k 0.7× 2.5k 1.0× 1.1k 0.7× 905 0.7× 207 6.9k
Edzard Schwedhelm 3.0k 0.8× 3.3k 1.2× 1.7k 0.7× 928 0.6× 804 0.6× 239 8.5k

Countries citing papers authored by Eberhard Schulz

Since Specialization
Citations

This map shows the geographic impact of Eberhard Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eberhard Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eberhard Schulz more than expected).

Fields of papers citing papers by Eberhard Schulz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eberhard Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eberhard Schulz. The network helps show where Eberhard Schulz may publish in the future.

Co-authorship network of co-authors of Eberhard Schulz

This figure shows the co-authorship network connecting the top 25 collaborators of Eberhard Schulz. A scholar is included among the top collaborators of Eberhard Schulz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eberhard Schulz. Eberhard Schulz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jansen, Thomas, Miroslava Kvandová, Sanela Kalinovic, et al.. (2021). Lack of Endothelial α1AMPK Reverses the Vascular Protective Effects of Exercise by Causing eNOS Uncoupling. Antioxidants. 10(12). 1974–1974. 5 indexed citations
2.
Stamm, Paul, Matthias Oelze, Sebastian Steven, et al.. (2021). Direct comparison of inorganic nitrite and nitrate on vascular dysfunction and oxidative damage in experimental arterial hypertension. Nitric Oxide. 113-114. 57–69. 20 indexed citations
3.
Göbel, Sebastian, Thomas Jansen, Susanne Karbach, et al.. (2020). Safety of Transradial and Transfemoral Left Ventricular Compared with Transfemoral Right Ventricular Endomyocardial Biopsy. ESC Heart Failure. 7(6). 4015–4023. 8 indexed citations
4.
Geyer, Martin, Karsten Keller, Efthymios Sotiriou, et al.. (2020). Association of Transcatheter Direct Mitral Annuloplasty with Acute Anatomic, Haemodynamic, and Clinical Outcomes in Severe Mitral Valve Regurgitation. ESC Heart Failure. 7(6). 3336–3344. 3 indexed citations
5.
Sotiriou, Efthymios, Susanne Heiner, Thomas Jansen, et al.. (2018). Therapeutic Implications of a Combined Diagnostic Workup Including Endomyocardial Biopsy in an All-Comer Population of Patients with Heart Failure: A Retrospective Analysis. ESC Heart Failure. 5(4). 630–641. 15 indexed citations
6.
Schulz, Eberhard, Alexander Jabs, Alexander Tamm, et al.. (2017). Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort. International Journal of Cardiology. 232. 186–191. 10 indexed citations
7.
Daiber, Andreas, Fabio Di Lisa, Matthias Oelze, et al.. (2015). Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function. British Journal of Pharmacology. 174(12). 1670–1689. 213 indexed citations
8.
Brugaletta, Salvatore, Tommaso Gori, Adrian F. Low, et al.. (2015). Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison. JACC: Cardiovascular Interventions. 8(1). 189–197. 115 indexed citations
9.
Gori, Tommaso, Eberhard Schulz, & Thomas Münzel. (2014). Anatomic Stabilization and Functional Normalization of a Ruptured Coronary Plaque 12 Months After Implantation of a Bioresorbable Scaffold. JACC: Cardiovascular Interventions. 7(5). e47–e48.
10.
Kröller‐Schön, Swenja, Sebastian Steven, Sabine Kossmann, et al.. (2013). Molecular Mechanisms of the Crosstalk Between Mitochondria and NADPH Oxidase Through Reactive Oxygen Species—Studies in White Blood Cells and in Animal Models. Antioxidants and Redox Signaling. 20(2). 247–266. 210 indexed citations
11.
Schulz, Eberhard, Philip Wenzel, Thomas Münzel, & Andreas Daiber. (2012). Mitochondrial Redox Signaling: Interaction of Mitochondrial Reactive Oxygen Species with Other Sources of Oxidative Stress. Antioxidants and Redox Signaling. 20(2). 308–324. 209 indexed citations
12.
Schuhmacher, Swenja, Marc Foretz, Maike Knorr, et al.. (2010). Abstract 13469: Alpha1-AMPK Deletion Enhances Endothelial Dysfunction and Vascular Oxidative Stress During Chronic Angiotensin II Treatment by Upregulation of Nox2. Circulation. 122. 1 indexed citations
13.
Schuhmacher, Swenja, Eberhard Schulz, Matthias Oelze, et al.. (2009). A new class of organic nitrates: investigations on bioactivation, tolerance and cross‐tolerance phenomena. British Journal of Pharmacology. 158(2). 510–520. 30 indexed citations
14.
Dittmann, Regina, Franz Joseph Freisleder, Helmut Remschmidt, et al.. (2008). Effectiveness and Tolerability of Olanzapine in the Treatment of Adolescents with Schizophrenia and Related Psychotic Disorders: Results from a Large, Prospective, Open-Label Study. Journal of Child and Adolescent Psychopharmacology. 18(1). 54–69. 29 indexed citations
15.
Fleischhaker, Christian, Philip Heiser, Klaus Hennighausen, et al.. (2006). Clinical Drug Monitoring in Child and Adolescent Psychiatry: Side Effects of Atypical Neuroleptics. Journal of Child and Adolescent Psychopharmacology. 16(3). 308–316. 43 indexed citations
16.
Mollnau, Hanke, Matthias Oelze, Michael August, et al.. (2005). Mechanisms of Increased Vascular Superoxide Production in an Experimental Model of Idiopathic Dilated Cardiomyopathy. Arteriosclerosis Thrombosis and Vascular Biology. 25(12). 2554–2559. 55 indexed citations
17.
Sydow, Karsten, Andreas Daiber, Matthias Oelze, et al.. (2004). Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. Journal of Clinical Investigation. 113(3). 482–489. 236 indexed citations
18.
Remschmidt, Helmut, et al.. (1994). An Open Trial of Clozapine in Thirty-Six Adolescents with Schizophrenia. Journal of Child and Adolescent Psychopharmacology. 4(1). 31–41. 54 indexed citations
19.
Schulz, Eberhard, et al.. (1984). Bewegung in der deutschen Frage? : die ausländischen Besorgnisse über die Entwicklung in den beiden deutschen Staaten.
20.
Schulz, Eberhard, K. Koch, & F. H. Schmidt. (1971). Ursachen der Potenzierung der hypoglykmischen Wirkung von Sulfonylharnstoff-Derivaten durch Medikamente: II. Pharmakokinetik und Metabolismus von Glibenclamid (HB 419) in Gegenwart von Phenylbutazon. European Journal of Clinical Pharmacology. 4(1). 32–37. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rita C. Tostes Breakdown of academic impact, for papers by Ákos Koller Breakdown of academic impact, for papers by Dan E. Berkowitz Breakdown of academic impact, for papers by Christopher G. Sobey Breakdown of academic impact, for papers by John Pernow Breakdown of academic impact, for papers by Jürgen C. Frölich Breakdown of academic impact, for papers by Ismail Laher Breakdown of academic impact, for papers by Philip J. Kadowitz Breakdown of academic impact, for papers by R. Clinton Webb Breakdown of academic impact, for papers by Edzard Schwedhelm
Rankless by CCL
2026